STOCKWATCH
·
Pharmaceuticals
Business Update7 Aug 2025, 10:18 am

Sigachi Industries Accelerates Growth with New MCC Capacity at Dahej SEZ; Reaffirms Commitment to Safety, Resilience, and Global Leadership

AI Summary

Sigachi Industries Limited, a leading manufacturer of pharmaceutical excipients, APIs, and specialty ingredients, has announced the initiation of civil works for its next phase of capacity expansion—an advanced 12,000 MTPA Microcrystalline Cellulose (MCC) project at its Dahej SEZ unit in Gujarat. This strategic move aligns with Sigachi’s long-term vision of operational resilience, safety-first design, and continued global leadership in the excipient industry. The new capacity is expected to be operational within 9 months, reinforcing business continuity and cementing Sigachi’s position as the Largest Manufacturer in India and among the top in the world. The expansion strategy is designed for safety and excellence, with a new Spray Dryer system being procured in consultation with reputed equipment manufacturers and safety experts.

Key Highlights

  • 12,000 MTPA MCC Capacity to be added at Dahej SEZ, operational within 9 months.
  • Designed for Safety & Excellence: The new Spray Dryer system is being procured in consultation with reputed equipment manufacturers and safety experts.
  • Total Installed MCC Capacity will rise to 30,000 MTPA, cementing Sigachi’s position as the Largest Manufacturer in India and among the top in the world.
  • Reinforced Business Continuity: This new capacity at Dahej SEZ, along with increased production at our Jnagadia and Dahej SEZ (existing) facilities, will help us continue serving our customers without any disruption in supply.
SIGACHI
Pharmaceuticals
Sigachi Industries Ltd

Price Impact